This is the authors' abstract. We don't add key points for this paper.
Asymmetric transformation of (RS)-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid [(RS)-TIC] by use of (1S)-10-camphorsulfonic acid [(S)-CS] as a resolving agent gave a salt of (S)-TIC with (S)-CS with 90% optical purity in hexanoic acid. The TIC obtained from the salt was purified to give optically pure (S)-TIC in 80% yield based on the starting (RS)-TIC.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Shiraiwa et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: